{"id":"https://openalex.org/W4241546483","doi":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4863","title":"Diabetic Ketoacidosis as an Initial Presentation of Anti-PD-L1 Antibody Durvalumab-Induced Diabetes Mellitus","display_name":"Diabetic Ketoacidosis as an Initial Presentation of Anti-PD-L1 Antibody Durvalumab-Induced Diabetes Mellitus","alternate_titles":[],"publication_year":2021,"publication_date":"2021-05-01","ids":{"openalex":"https://openalex.org/W4241546483","doi":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4863"},"language":"en","primary_location":{"id":"doi:10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4863","doi":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4863","is_oa":true,"landing_page_url":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4863","pdf_url":"https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A4863","source":{"id":"https://openalex.org/S93356601","display_name":"American Journal of Respiratory and Critical Care Medicine","issn_l":"1073-449X","issn":["1073-449X","1535-4970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316311","host_organization_name":"American Thoracic Society","host_organization_lineage":["https://openalex.org/P4310316311"],"host_organization_lineage_names":["American Thoracic Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"TP139. TP139 THORACIC ONCOLOGY: CASE REPORTS - NON-SMALL CELL LUNG CANCER","raw_type":"proceedings-article"},"parent_works":[],"lineage":["https://openalex.org/W4241546483"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A4863","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021415311","display_name":"S. Reid","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166722992","display_name":"University of Massachusetts Chan Medical School","ror":"https://ror.org/0464eyp60","country_code":"US","type":"education","lineage":["https://openalex.org/I166722992"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Reid","raw_affiliation_strings":["Department of Medicine, University of Massachusetts Medical School, Worcester, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Massachusetts Medical School, Worcester, MA, United States","institution_ids":["https://openalex.org/I166722992"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047050213","display_name":"O. Bruck","orcid":"https://orcid.org/0009-0000-5149-0933","observed_orcids":["https://orcid.org/0009-0000-5149-0933"]},"institutions":[{"id":"https://openalex.org/I166722992","display_name":"University of Massachusetts Chan Medical School","ror":"https://ror.org/0464eyp60","country_code":"US","type":"education","lineage":["https://openalex.org/I166722992"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"O. Bruck","raw_affiliation_strings":["Department of Medicine, University of Massachusetts Medical School, Worcester, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Massachusetts Medical School, Worcester, MA, United States","institution_ids":["https://openalex.org/I166722992"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I166722992"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A4863","last_page":"A4863"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8628000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8628000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.08460000157356262,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.010499999858438969,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.9359999895095825},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.7649999856948853},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.6060000061988831},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.8859999775886536},{"id":"https://openalex.org/keywords/new-onset-diabetes","display_name":"new-onset diabetes","score":0.8330000042915344},{"id":"https://openalex.org/keywords/diabetic-ketoacidosis","display_name":"diabetic ketoacidosis","score":0.8309999704360962},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9340000152587891},{"id":"https://openalex.org/keywords/gad65-autoantibodies","display_name":"GAD65 antibodies","score":0.7400000095367432},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.6959999799728394},{"id":"https://openalex.org/keywords/metabolic-acidosis","display_name":"metabolic acidosis","score":0.7269999980926514},{"id":"https://openalex.org/keywords/hypokalemia","display_name":"hypokalemia","score":0.6359999775886536},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.5709999799728394}],"concepts":[{"id":"https://openalex.org/C2781283889","wikidata":"https://www.wikidata.org/wiki/Q1130148","display_name":"Diabetic ketoacidosis","level":3,"score":0.8865404725074768},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.7813370823860168},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.7188924551010132},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7016210556030273},{"id":"https://openalex.org/C2777601897","wikidata":"https://www.wikidata.org/wiki/Q3409113","display_name":"Presentation (obstetrics)","level":2,"score":0.659631073474884},{"id":"https://openalex.org/C2775849729","wikidata":"https://www.wikidata.org/wiki/Q1130148","display_name":"Ketoacidosis","level":4,"score":0.4817507266998291},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.45394355058670044},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37179505825042725},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.29460012912750244},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2080574333667755},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.18682199716567993},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.17870479822158813},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.12814611196517944},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.10202136635780334},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.05628734827041626}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4863","doi":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4863","is_oa":true,"landing_page_url":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4863","pdf_url":"https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A4863","source":{"id":"https://openalex.org/S93356601","display_name":"American Journal of Respiratory and Critical Care Medicine","issn_l":"1073-449X","issn":["1073-449X","1535-4970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316311","host_organization_name":"American Thoracic Society","host_organization_lineage":["https://openalex.org/P4310316311"],"host_organization_lineage_names":["American Thoracic Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"TP139. TP139 THORACIC ONCOLOGY: CASE REPORTS - NON-SMALL CELL LUNG CANCER","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4863","doi":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4863","is_oa":true,"landing_page_url":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4863","pdf_url":"https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A4863","source":{"id":"https://openalex.org/S93356601","display_name":"American Journal of Respiratory and Critical Care Medicine","issn_l":"1073-449X","issn":["1073-449X","1535-4970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316311","host_organization_name":"American Thoracic Society","host_organization_lineage":["https://openalex.org/P4310316311"],"host_organization_lineage_names":["American Thoracic Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"TP139. TP139 THORACIC ONCOLOGY: CASE REPORTS - NON-SMALL CELL LUNG CANCER","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4241546483.pdf","grobid_xml":"https://content.openalex.org/works/W4241546483.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2996460284","https://openalex.org/W2957441136","https://openalex.org/W3085655576","https://openalex.org/W4409213371","https://openalex.org/W2944366650","https://openalex.org/W3009571804","https://openalex.org/W3130144249","https://openalex.org/W4308136022","https://openalex.org/W2944459643","https://openalex.org/W2943980127"],"abstract_inverted_index":{"A":[0],"71":[1],"year":[2],"old":[3],"female":[4],"with":[5,19,22,106,124,183,203,246,305],"a":[6,64,107,142,180,199,211,306,342,347],"history":[7,119],"of":[8,14,25,31,66,76,79,82,85,88,95,109,115,120,137,150,221,234,252,261,286,320,330,368],"hypothyroidism":[9],"and":[10,28,38,58,90,113,127,141,153,173,194,313],"non-small":[11,225,237],"cell":[12,226,238],"adenocarcinoma":[13],"the":[15,131,148,219,232,250,262,266,327,337,364],"lung":[16,227,239],"on":[17,270],"immunotherapy":[18],"durvalumab":[20,41,235,247,296],"presented":[21,301],"two":[23],"days":[24,43],"nausea,":[26],"vomiting,":[27],"generalized":[29],"malaise.Review":[30],"systems":[32],"was":[33,52,98,122,128,156,176,196],"positive":[34,167,289,314],"for":[35,54,135,205,218,236,350],"new-onset":[36,269,287],"polyuria":[37],"polydipsia.She":[39],"received":[40],"five":[42],"prior":[44],"to":[45,130,165,198,256,295,361],"presentation.Initial":[46],"vital":[47],"signs":[48],"were":[49,163,254],"unremarkable.Physical":[50],"examination":[51],"significant":[53,71,242],"decreased":[55],"skin":[56],"turgor":[57],"dry":[59],"mucous":[60],"membranes.Laboratory":[61],"studies":[62],"revealed":[63],"leukocytosis":[65],"18.7,":[67],"as":[68,70,324,326],"well":[69,325],"metabolic":[72,104],"abnormalities,":[73],"including":[74],"sodium":[75],"124mEq/L,":[77],"potassium":[78],"5.2mEq/L,":[80],"chloride":[81],"83mEq/L,":[83],"bicarbonate":[84,114],"16mEq/L,":[86],"creatinine":[87],"2.14mg/dL,":[89],"most":[91],"significantly,":[92],"blood":[93,101,307],"glucose":[94,308],"1,150g/dL.Anion":[96],"gap":[97,189],"25.A":[99],"venous":[100],"gas":[102],"demonstrated":[103,147],"acidosis":[105],"pH":[108],"7.21,":[110],"pCO2":[111],"40,":[112],"15.She":[116],"had":[117],"no":[118],"hyperglycemia.She":[121],"diagnosed":[123],"diabetic":[125,303],"ketoacidosis":[126,304],"admitted":[129],"intensive":[132],"care":[133],"unit":[134],"administration":[136],"IV":[138],"normal":[139],"saline":[140],"continuous":[143],"insulin":[144,201],"infusion.Further":[145],"workup":[146],"presence":[149],"both":[151],"urine":[152],"serum":[154],"ketones.HbA1c":[155],"mildly":[157],"elevated":[158],"at":[159,168,178],"6.9%.Anti-GAD":[160],"65":[161,316],"antibodies":[162],"found":[164],"be":[166],"greater":[169],"than":[170],"25,000":[171],"U/mL":[172],"c-peptide":[174],"level":[175],"low":[177,311],"0.2ng/mL,":[179],"pattern":[181],"consistent":[182],"type":[184,271,290,332],"I":[185],"diabetes":[186,273,292,334],"mellitus.Her":[187],"anion":[188],"closed":[190],"within":[191],"six":[192],"hours":[193],"she":[195],"transitioned":[197],"basal-bolus":[200],"regimen":[202],"plans":[204],"outpatient":[206],"endocrinology":[207],"follow":[208],"up.Durvalumab":[209],"is":[210],"programmed":[212],"death-ligand":[213],"1":[214,272,291,333],"(PD-L1)":[215],"inhibitor":[216],"approved":[217],"treatment":[220],"stage":[222],"III":[223],"non-resectable":[224],"cancer.The":[228],"first":[229],"trial":[230,267],"examining":[231],"use":[233],"cancer":[240],"noted":[241],"adverse":[243,366],"endocrine":[244],"events":[245],"use,":[248],"however,":[249],"majority":[251],"these":[253,369],"related":[255],"thyroid":[257],"function.Only":[258],"one":[259],"out":[260],"1,414":[263],"patients":[264],"in":[265,302,336,353],"developed":[268],"mellitus":[274,293,335],"(<0.001%).Since":[275],"that":[276],"trial,":[277],"there":[278],"have":[279],"been":[280],"only":[281],"three":[282],"published":[283],"case":[284,341],"reports":[285],"antibody":[288],"connected":[294],"use.The":[297],"patient":[298],"discussed":[299],"here":[300],"above":[309],"1,100,":[310],"C-peptide,":[312],"anti-GAD":[315],"antibodies.The":[317],"rapid":[318],"progression":[319],"her":[321],"clinical":[322],"course,":[323],"relative":[328],"rarity":[329],"durvalumab-induced":[331],"literature":[338],"make":[339],"this":[340],"notable":[343],"one.Immune":[344],"checkpoints":[345],"remain":[346],"promising":[348],"target":[349],"pharmacologic":[351],"agents":[352],"treating":[354],"oncologic":[355],"conditions,":[356],"however":[357],"science":[358],"has":[359],"yet":[360],"fully":[362],"elucidate":[363],"potential":[365],"effects":[367],"medications.":[370]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4241546483","counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2022-05-12T00:00:00"}
